Enzymatica AB (publ) Stock

Enzymatica AB (publ) P/E 2024

Enzymatica AB (publ) P/E

-6.55

Ticker

ENZY.ST

ISIN

SE0003943620

WKN

A1WZEV

As of Sep 11, 2024, Enzymatica AB (publ)'s P/E ratio was -6.55, a -26.65% change from the -8.93 P/E ratio recorded in the previous year.

The Enzymatica AB (publ) P/E history

Enzymatica AB (publ) Aktienanalyse

What does Enzymatica AB (publ) do?

Enzymatica AB (publ) is a Swedish healthcare company that specializes in the development, production, and marketing of enzyme technology. It was founded in 2007 and is headquartered in Lund, Sweden. The company is listed on the Nasdaq Stockholm. Enzymatica AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Enzymatica AB (publ)'s P/E Ratio

The Price to Earnings (P/E) Ratio of Enzymatica AB (publ) is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Enzymatica AB (publ)'s P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Enzymatica AB (publ) is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Enzymatica AB (publ)’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Enzymatica AB (publ) stock

What is the price-to-earnings ratio of Enzymatica AB (publ)?

The price-earnings ratio of Enzymatica AB (publ) is currently -6.55.

How has the price-earnings ratio of Enzymatica AB (publ) changed compared to last year?

The price-to-earnings ratio of Enzymatica AB (publ) has increased by -26.65% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Enzymatica AB (publ) high compared to other companies?

Yes, the price-to-earnings ratio of Enzymatica AB (publ) is high compared to other companies.

How does an increase in the price-earnings ratio of Enzymatica AB (publ) affect the company?

An increase in the price-earnings ratio of Enzymatica AB (publ) would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Enzymatica AB (publ) affect the company?

A decrease in the price-earnings ratio of Enzymatica AB (publ) would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Enzymatica AB (publ)?

Some factors that influence the price-earnings ratio of Enzymatica AB (publ) are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Enzymatica AB (publ) pay?

Over the past 12 months, Enzymatica AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enzymatica AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of Enzymatica AB (publ)?

The current dividend yield of Enzymatica AB (publ) is .

When does Enzymatica AB (publ) pay dividends?

Enzymatica AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzymatica AB (publ)?

Enzymatica AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Enzymatica AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzymatica AB (publ) located?

Enzymatica AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzymatica AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzymatica AB (publ) from 9/11/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did Enzymatica AB (publ) pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of Enzymatica AB (publ) in the year 2023?

In the year 2023, Enzymatica AB (publ) distributed 0 SEK as dividends.

In which currency does Enzymatica AB (publ) pay out the dividend?

The dividends of Enzymatica AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enzymatica AB (publ)

Our stock analysis for Enzymatica AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzymatica AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.